../1198/space%20holder

../1198/space%20holder

Next Gazetteer item | Sept/Oct Contents | Gazette home





BIOETHICS

Glenn McGee on Brits,
Yanks and … Male Birthing

 

Last fall, Dr. Glenn McGee, assistant professor of bioethics and associate director for education at Penn’s Center for Bioethics, traveled to Britain as an Atlantic Fellow in Public Policy. There he found himself straddling the fault lines of an ever-shifting field in which the very essence of life is subject to cloning, patenting and politics. When he returned to Penn in the spring, McGee—who is also editor-in-chief of the American Journal of Bioethics and of the Basic Bioethics book series for MIT Press—fielded some questions from the Gazette about his experiences abroad.

Gazette: Can you offer any general observations about the difference between the British approach to bioethics and the American?
McGee: I went to Britain with typical American cynicism about the ability of the English academic system to give practical advice to policymakers about tough issues. I had worked with Ian Wilmut, the Scottish scientist most responsible for cloning Dolly the sheep. Before I was nominated to be a Fellow with an All Access pass to the British government, I had laughed at the difference between our robust American debate about cloning, and the tame pronouncements of a few philosophers in Britain. How wrong I was. The British system for discussing policy and practice in medicine only appears stodgy from 3,000 miles away. Up close it is a beehive of ethical debate.
    My research agenda—to study the differences between U.S. and U.K. policy about reproduction—quickly mushroomed into a comprehensive fire-fighting mission, as I was called to participate in dozens of high-level conversations and task forces about genetics, reproduction, patenting, biotechnology and the woes of national health insurance. Where we have Camelot-style ethics debate in a powerless presidential bioethics commission, the British involve ethics in literally every stage of health policy and publish its implications on the front page of every day’s paper. They don’t have bioethics as we know it, with centers like the one at Penn, and in that respect they, like the rest of the world, are playing a slow game of catch-up to develop our kind of teaching and research skills. But what they have that we lack is a profound integration of ethics and practice. Civility and a powerful role for the prime minister really pay off in public policy.
    Among the more profound differences between American and British medicine is the way each sees reproduction. To put it in ordinary language, the British put the analysis of potential problems in reproduction ahead of the development of technologies, while we Americans tend to rush headlong into developing technologies and tend to see reflection on the ethical dimensions of reproduction as either paternalistic or a matter for the market to resolve.
    Take egg donation. Only recently introduced to British medicine, and then only after the approval of the British Human Fertilization and Embryo Authority, egg-transfer from donors to other women who want to carry their children in their womb requires several steps of interviews and approvals in the U.K. In the U.S., we regulate the sale of parakeets more strictly than the donation of eggs, and stories about how much money college women earn by “donating” their eggs through Web sites, ads in Ivy League newspapers, and even on EBay, will live on in the halls of medical fame.

Gazette: One often senses a strong anti-American undercurrent among British intellectuals. Does that ever fuel bioethical debates?
McGee: The British hate American bioethics, but love it all the same. I was forever invited to lunch, dinner, pubs, talks and even churches to sit quietly and listen to the Brits mock our superficial and elitist health system, or to say a few words so that an Oxford don would have someone to fight. I enjoyed that for a while, but I really started to miss all things American, even the things I myself had criticized about our health care, as I found all that I represented under such constant attack. Study abroad, even in our cousin nation of Britain, is a moving and emotional experience, in part because you are a symbol almost all of every day. I took notice, for example, of the positive effect a “British haircut” had; suddenly I didn’t get jostled as much on the Tube or ignored in line at the grocery.

Gazette: I also sense more distrust of technology and corporate business in general. Is that true (and relevant)?
McGee: One of the most interesting developments while I was in Britain was the American and British mutual interest in genetically modified [GM] foods. I and most of my colleagues suspected that the reason the British distrust GM foods was their love of the natural, their bucolic longing for a time when things were unadulterated and real. Wrong. Lots of time and conversation with dozens of those involved in or just watching the British side convinced me that the U.K. distaste for genetically modified food is much more about fear of what is viewed as an American carelessness with biotechnology. We have much to lose in the global debates about biotechnology, and lesson number one is to recognize the importance of demonstrating the safety and benefit of each and every attempt to improve food before we bring new food products to the market and the world.

Gazette: The recent joint statement by Clinton and Blair opposing the patenting of genes caused some ripples in the biotechnology industry,
and I gather you participated in that debate to some degree. What were the subtexts of that statement?

McGee: If everyone gets 15 minutes of time to communicate their message to the world, I hope that the Clinton-Blair announcement doesn’t run down my clock.
    Indeed I did advise both sides about the announcement, and in that sense I take some small measure of blame for the ridiculous effect that statement had, though both sides ignored my plea that there be a clear message about what counts as patentable subject matter. Instead they made a strange statement that was toothless enough to encourage biotechnology to keep patenting everything it does, while crushing investor confidence in everything technological based on a false fear that both sides would be banning patenting. It just goes to show how difficult top-down bioethics can be, even in Britain.

Gazette: Any other recent shifts in British-American bioethics that you’ve noticed and/or participated in?
McGee: One of the most interesting developments while I was in Britain was the announcement of an “intestinal pregnancy,” which happened when a woman’s fetus attached itself to the lining of her intestines and was successfully sustained by placental tissue that grew there. A prominent British researcher interested in male pregnancy seized that and other developments to really push the idea of getting men pregnant. I found that fascinating and had a great opportunity to interview men who were potential candidates for such a procedure. I plan to write about male pregnancy during the coming months.

Gazette: That’s quite a bombshell. Could you talk a little about the researcher who’s pushing this and some of those potential candidates for the procedure?
McGee: Male pregnancy, when it happens, will not be the offspring of some crackpot British biologist. No less a scholar and scientist than the head of Britain’s prestigious Hammersmith Hospital, Lord Robert Winston, a prominent reproductive endocrinologist who conducted some of the most important early experiments in in-vitro fertilization, is pushing the idea along. Winston believes that there is no obvious reason why males should not share more fully in the birthing process, and while I can’t see a big market for male birthing, already I had the opportunity to interview several men who have volunteered for clinical trials of this technology as it develops.

Gazette: Shock-value aside, isn’t this a really bad thing to ask your intestines to handle?
McGee: Some of the obvious risks include rupture of the intestinal lining, acute rejection of the fetus, and lord only knows what sort of hormonal imbalance. But Americans, who warmed to the idea of Arnold Schwarzenegger as a male mom in a 1980s movie, may be among the first to have the opportunity to really spread the pleasures and burdens of pregnancy around. As a philosopher I am fascinated at the implications of male pregnancy for all of the ways in which we have traditionally defined human flourishing. As a guy the whole thing has me fascinated yet oddly repulsed. It promises to continue to be a rich area for ethical and scientific research.


Next Gazetteer item | Sept/Oct Contents | Gazette home


Copyright 2000 The Pennsylvania Gazette Last modified 7/21/00